MTX vs. Ciclosporin for Severe Atopic Eczema in Children MTX vs. Ciclosporin for Severe Atopic Eczema in Children
This study aims to compare the effectiveness, safety, cost-effectiveness and impact on patient ' s quality of life of methotrexate vs. ciclosporin for refractory atopic eczema in children.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 28, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Does Methotrexate Work in Giant Cell Arteritis?
(MedPage Today) -- Methotrexate add-on to glucocorticoid decreased rate of subsequent relapse by nearly two-fold (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 26, 2019 Category: Primary Care Source Type: news
methotrexate (Rheumatrex, Trexall)
Title: methotrexate (Rheumatrex, Trexall)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/14/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - December 14, 2018 Category: Dermatology Source Type: news
'Chemo brain' caused by malfunction in three types of brain cells, Stanford study finds
(Stanford Medicine) In a new study explaining the cellular mechanisms behind cognitive impairment from chemotherapy, scientists at the Stanford University School of Medicine have demonstrated that a widely used chemotherapy drug, methotrexate, causes a complex set of problems in three major cell types within the brain's white matter. The study, which will be published online Dec. 6 in Cell, also identifies a potential remedy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news
CIRT: Methotrexate Fails to Cut CV Events CIRT: Methotrexate Fails to Cut CV Events
Though negative, the results provide vital information on the underlying biology that connects inflammation with cardiovascular disease, experts say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 11, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
AHA: Targeting Inflammation With Methotrexate Flops for CV Prevention
(MedPage Today) -- CIRT trial disappoints after CANTOS ' win for the inflammatory hypothesis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 10, 2018 Category: Cardiology Source Type: news
Low-Dose Methotrexate Does Not Reduce Risk of Cardiovascular Events
Inexpensive generic drug neither inhibited critical inflammatory pathways nor reduced rates of heart attack, stroke and cardiovascular death (Source: BWH News)
Source: BWH News - November 10, 2018 Category: Hospital Management Source Type: news
Medical News Today: Methotrexate and folic acid for rheumatoid arthritis
Doctors sometimes prescribe methotrexate for rheumatoid arthritis (RA), but it can lead to folic acid deficiencies. Learn more about managing this and other side effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 29, 2018 Category: Consumer Health News Tags: Rheumatoid Arthritis Source Type: news
First Head-to-Head Trial of a TNF Inhibitor Versus Methotrexate Monotherapy in Psoriatic Arthritis Shows ENBREL ® (Etanercept) Monotherapy and Combination Therapy Both Superior to Methotrexate
Results From Head-To-Head Phase 3 SEAM-PsA Study Assessing ENBREL and Methotrexate Regimens in Patients With Psoriatic Arthritis Presented at 2018 ACR/ARHP Annual Meeting
Additional Phase 3b Results Show Modified ENBREL Formulation Associated With Significantly Lower Mean Injection Site Pain Versus Prior Formulation
Data Presentations Result of Continued Dedication to Evaluate Optimal Use of ENBREL
THOUSAND OAKS, Calif., Oct. 24, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that positive results from the Phase 3 SEAM-PsA study comparing the efficacy of Enbrel® (etanercept) monotherapy and ENBREL plus ...
Source: Amgen News Release - October 24, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news
AbbVie rheumatoid arthritis drug succeeds in late stage trial
AbbVie Inc on Tuesday said its experimental rheumatoid arthritis (RA) treatment showed significant improvement in physical function, pain and quality of life compared with the commonly prescribed generic drug methotrexate in a late stage clinical trial. (Source: Reuters: Health)
Source: Reuters: Health - October 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
In Peripheral Spondyloarthritis, Early Biologic Needed In Peripheral Spondyloarthritis, Early Biologic Needed
New data from the CRESPA extension study show that the addition of methotrexate during biologic tapering has no significant effect on remission in peripheral spondyloarthritis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Methotrexate Effective in Subcutaneous Psoriasis
(MedPage Today) -- Over 40% of patients achieved PASI 75 response in 16-week trial (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 15, 2018 Category: Dermatology Source Type: news
Subq Methotrexate Effective in Psoriasis
(MedPage Today) -- Over 40% of patients achieved PASI 75 response in 16-week trial (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 15, 2018 Category: Dermatology Source Type: news
Text Message: Take Your Methotrexate! (CME/CE)
(MedPage Today) -- Pilot program found better adherence in rheumatoid arthritis patients with weekly reminders (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 14, 2018 Category: Rheumatology Source Type: news
Double the Risk for Neurotoxicity for Hispanic Kids From ALL Rx Double the Risk for Neurotoxicity for Hispanic Kids From ALL Rx
Minority children, notably Hispanics, are more susceptible to developing methotrexate-induced neurotoxicity than non-Hispanic children during treatment for acute lymphoblastic leukemia (ALL).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
